Microvascular Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersTucson, AZ
US patents3
SAM.gov UEIZA54X6LR5AS3
CAGE code7LE82
Incorporated inDE
- ultrasound contrast
- theranostics
- nanobubbles
- microbubbles
- completed Phase II clinical trials
- MVT-100
- tumor ablation
- deep vein thrombosis
- brain cancer
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
3 US patents granted 2017–2021, 1 of them in the five years to SEP 2025.
Pharmaceuticals 3
- Phospholipid composition and microbubbles and emulsions formed using sameUS 11,160,885 · granted NOV 2, 2021
- Phospholipid composition and microbubbles and emulsions formed using sameUS 10,493,173 · granted DEC 3, 2019
- Phospholipid composition and microbubbles and emulsions formed using sameUS 9,801,959 · granted OCT 31, 2017
Granted to Microvascular Therapeutics LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Microvascular Therapeutics INC | Tucson | AZ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.